Koers Xtant Medical Holdings Inc Nyse
Aandelen
US98420P1003
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 116 mln. 107 mln. | Omzet 2025 * | 131 mln. 121 mln. | Marktkapitalisatie | 98,12 mln. 90,47 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -10 mln. -9,22 mln. | Nettowinst (verlies) 2025 * | -1 mln. -922K | EV/omzet 2024 * | 0,85 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,75 x |
K/w-verhouding 2024 * |
-9,42
x | K/w-verhouding 2025 * |
-75,4
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 91,7% |
Recentste transcriptie over Xtant Medical Holdings Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sean Browne
CEO | Chief Executive Officer | 58 | 07-10-19 |
Scott Neils
DFI | Director of Finance/CFO | 40 | 01-08-19 |
Chief Operating Officer | - | 16-01-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 58 | 16-05-23 | |
John Bakewell
BRD | Director/Board Member | 62 | 01-02-18 |
Robert McNamara
BRD | Director/Board Member | 67 | 01-02-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,37% | 126 mld. | |
-5,45% | 11,3 mld. | |
+4,83% | 9,16 mld. | |
+36,53% | 5,46 mld. | |
-25,10% | 4,53 mld. | |
+8,61% | 3,45 mld. | |
-10,05% | 2,76 mld. | |
-10,99% | 2,09 mld. | |
-10,20% | 2 mld. |